Computer- and NMR-Aided Design of Small-Molecule Inhibitors of the Hub1 Protein

被引:1
|
作者
Romero, Atilio Reyes [1 ,2 ]
Kubica, Katarzyna [1 ]
Kitel, Radoslaw [1 ]
Rodriguez, Ismael [1 ]
Magiera-Mularz, Katarzyna [1 ]
Domling, Alexander [2 ]
Holak, Tad A. [1 ]
Surmiak, Ewa [1 ]
机构
[1] Jagiellonian Univ, Fac Chem, Dept Organ Chem, Gronostajowa 2, PL-30387 Krakow, Poland
[2] Univ Groningen, Dept Drug Design, A Deusinglaan 1, NL-9713 AV Groningen, Netherlands
来源
MOLECULES | 2022年 / 27卷 / 23期
关键词
protein-protein interactions; anti-cancer therapy; nuclear magnetic resonance; protein-peptide docking; small-molecule inhibitors; DRUG DISCOVERY; UBL5; GENE; UBIQUITIN; DOCKING; RECOGNITION; PEPTIDES; BINDING;
D O I
10.3390/molecules27238282
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
By binding to the spliceosomal protein Snu66, the human ubiquitin-like protein Hub1 is a modulator of the spliceosome performance and facilitates alternative splicing. Small molecules that bind to Hub1 would be of interest to study the protein-protein interaction of Hub1/Snu66, which is linked to several human pathologies, such as hypercholesterolemia, premature aging, neurodegenerative diseases, and cancer. To identify small molecule ligands for Hub1, we used the interface analysis, peptide modeling of the Hub1/Snu66 interaction and the fragment-based NMR screening. Fragment-based NMR screening has not proven sufficient to unambiguously search for fragments that bind to the Hub1 protein. This was because the Snu66 binding pocket of Hub1 is occupied by pH-sensitive residues, making it difficult to distinguish between pH-induced NMR shifts and actual binding events. The NMR analyses were therefore verified experimentally by microscale thermophoresis and by NMR pH titration experiments. Our study found two small peptides that showed binding to Hub1. These peptides are the first small-molecule ligands reported to interact with the Hub1 protein.
引用
收藏
页数:15
相关论文
共 50 条
  • [21] Selectivity by Small-Molecule Inhibitors of Protein Interactions Can Be Driven by Protein Surface Fluctuations
    Johnson, David K.
    Karanicolas, John
    PLOS COMPUTATIONAL BIOLOGY, 2015, 11 (02)
  • [22] Targeting Oncogenic Eukaryotic Protein Translation in Thoracic Malignancies with Small-Molecule Inhibitors
    Ahmad, Zeeshan
    Jacobson, Blake
    Okon, Aniekan M.
    Patel, Manish
    Al Rawi, Ezzideen B.
    Vidal, Gabe Vattendahl
    Wagner, Carston R.
    Kratzke, Robert
    JOURNAL OF THORACIC ONCOLOGY, 2015, 10 (09) : S595 - S595
  • [23] Biomolecular Interactions of Small-molecule Inhibitors Affecting the YopH Protein Tyrosine Phosphatase
    Hogan, Megan
    Bahta, Medhanit
    Cherry, Scott
    Lountos, George T.
    Tropea, Joseph E.
    Zhao, Bryan M.
    Burke, Terrence R., Jr.
    Waugh, David S.
    Ulrich, Robert G.
    CHEMICAL BIOLOGY & DRUG DESIGN, 2013, 81 (03) : 323 - 333
  • [24] Structural features of the protein kinase domain and targeted binding by small-molecule inhibitors
    Arter, Chris
    Trask, Luke
    Ward, Sarah
    Yeoh, Sharon
    Bayliss, Richard
    JOURNAL OF BIOLOGICAL CHEMISTRY, 2022, 298 (08)
  • [25] Novel Small-Molecule Inhibitors of the SARS-CoV-2 Spike Protein Binding to Neuropilin 1
    Kolaric, Anja
    Jukic, Marko
    Bren, Urban
    PHARMACEUTICALS, 2022, 15 (02)
  • [26] Small-Molecule Inhibitors Targeting FEN1 for Cancer Therapy
    Yang, Fan
    Hu, Zhigang
    Guo, Zhigang
    BIOMOLECULES, 2022, 12 (07)
  • [27] Identification of Small-Molecule Inhibitors of the Antiapoptotic Protein Myeloid Cell Leukaemia-1 (Mcl-1)
    Beekman, Andrew M.
    O'Connell, Maria A.
    Howell, Lesley A.
    CHEMMEDCHEM, 2016, 11 (08) : 840 - 844
  • [28] Structure-Guided Synthesis and Evaluation of Small-Molecule Inhibitors Targeting Protein-Protein Interactions of BRCA1 tBRCT Domain
    Kurdekar, Vadiraj
    Giridharan, Saranya
    Subbarao, Jasti
    Nijaguna, Mamatha B.
    Periasamy, Jayaprakash
    Boggaram, Sanjana
    Shivange, Amol, V
    Sadasivam, Gayathri
    Padigaru, Muralidhara
    Potluri, Vijay
    Venkitaraman, Ashok R.
    Bharatham, Kavitha
    CHEMMEDCHEM, 2019, 14 (18) : 1620 - 1632
  • [29] From Determinants of RUNX1/ETO Tetramerization to Small-Molecule Protein-Protein Interaction Inhibitors Targeting Acute Myeloid Leukemia
    Metz, Alexander
    Schanda, Julia
    Grez, Manuel
    Wichmann, Christian
    Gohlke, Holger
    JOURNAL OF CHEMICAL INFORMATION AND MODELING, 2013, 53 (09) : 2197 - 2202
  • [30] Discovery of small-molecule inhibitors of RUVBL1/2 ATPase
    Zhang, Gang
    Wang, Feng
    Li, Shan
    Cheng, Kai-Wen
    Zhu, Yingying
    Huo, Ran
    Abdukirim, Elyar
    Kang, Guifeng
    Chou, Tsui-Fen
    BIOORGANIC & MEDICINAL CHEMISTRY, 2022, 62